| # | Drug | Count |
|---|---|---|
| 0 | SILDENAFIL CITRATE | 9 |
| 1 | SILDENAFIL | 7 |
| 2 | SILDENAFIL POWDER, | 6 |
| 3 | BLEOMYCIN | 4 |
| 4 | BLEOMYCIN SULFATE | 4 |
| 5 | CISPLATIN | 4 |
| 6 | ETOPOSIDE | 3 |
| 7 | OMEPRAZOLE MAGNESIUM | 3 |
| 8 | SIMVASTATIN | 3 |
| 9 | ABIRATERONE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BLEOMYCIN SULFATE | 4 | 0.0004 |
| 1 | ALPROSTADIL | 1 | 0.0003 |
| 2 | PENTOXIFYLLINE | 1 | 0.0002 |
| 3 | SILDENAFIL POWDER, | 6 | 0.0002 |
| 4 | NIACIN | 1 | 0.0001 |
| 5 | PEGASPARGASE | 1 | 0.0001 |
| 6 | SILDENAFIL CITRATE | 9 | 0.0001 |
| 7 | CISPLATIN | 4 | 0.0001 |
| 8 | ABIRATERONE ACETATE | 2 | 0.0000 |
| 9 | HYDROXYUREA | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 1 | Asparagine-specific Enzyme [EPC] | 1 | 0.0001 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 7 | 0.0001 |
| 3 | Topoisomerase Inhibitor [EPC] | 3 | 0.0000 |
| 4 | Central Nervous System Stimulant [EPC] | 2 | 0.0000 |
| 5 | Nicotinic Acid [EPC] | 1 | 0.0000 |
| 6 | Platinum-based Drug [EPC] | 4 | 0.0000 |
| 7 | Xanthine Oxidase Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Prostaglandin Analog [EPC] | 1 | 0.0000 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 3 | 0.0000 |